Nukkleus Stock Analysis

NUKK Stock  USD 0.96  0.04  4.35%   
Nukkleus is fairly valued with Real Value of 0.92 and Hype Value of 0.9. The main objective of Nukkleus stock analysis is to determine its intrinsic value, which is an estimate of what Nukkleus is worth, separate from its market price. There are two main types of Nukkleus' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Nukkleus' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Nukkleus' stock to identify patterns and trends that may indicate its future price movements.
The Nukkleus stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Nukkleus is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Nukkleus Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Nukkleus' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.

Nukkleus Stock Analysis Notes

The company recorded a loss per share of 0.02. Nukkleus had not issued any dividends in recent years. The entity had 140:100 split on the 26th of December 2023. Nukkleus Inc., a financial technology company, focuses on providing software and technology solutions for retail foreign exchange trading industry worldwide. Nukkleus Inc. operates as a subsidiary of Global Elite Holdings Ltd. Nukkleus operates under SoftwareApplication classification in the United States and is traded on OTC Exchange. It employs 12 people. To find out more about Nukkleus contact Emil Assentato at 212 791 4663 or learn more at https://www.nukk.com.

Nukkleus Quarterly Total Revenue

5.21 Million

Nukkleus Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Nukkleus' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Nukkleus or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Nukkleus had very high historical volatility over the last 90 days
Nukkleus has some characteristics of a very speculative penny stock
Nukkleus was previously known as Brilliant Acquisition Corp and was traded on NASDAQ Exchange under the symbol BRLI.
The company currently holds 3.65 M in liabilities. Nukkleus has a current ratio of 0.22, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Nukkleus until it has trouble settling it off, either with new capital or with free cash flow. So, Nukkleus' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nukkleus sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Nukkleus to invest in growth at high rates of return. When we think about Nukkleus' use of debt, we should always consider it together with cash and equity.
The entity reported the previous year's revenue of 21.51 M. Net Loss for the year was (11.85 M) with loss before overhead, payroll, taxes, and interest of (661.4 K).
Nukkleus has a poor financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Emil Assentato of 157500000 shares of Nukkleus subject to Rule 16b-3

Nukkleus Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 352.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Nukkleus's market, we take the total number of its shares issued and multiply it by Nukkleus's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Nukkleus Profitablity

Nukkleus' profitability indicators refer to fundamental financial ratios that showcase Nukkleus' ability to generate income relative to its revenue or operating costs. If, let's say, Nukkleus is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Nukkleus' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Nukkleus' profitability requires more research than a typical breakdown of Nukkleus' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.23) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.23.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.41)(1.48)
Return On Capital Employed(1.18)(1.12)
Return On Assets(0.79)(0.83)
Return On Equity(1.71)(1.62)

Management Efficiency

Nukkleus has return on total asset (ROA) of (0.1567) % which means that it has lost $0.1567 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7499) %, meaning that it created substantial loss on money invested by shareholders. Nukkleus' management efficiency ratios could be used to measure how well Nukkleus manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -1.48. Return On Capital Employed is expected to rise to -1.12 this year. Total Current Liabilities is expected to rise to about 9 M this year. Liabilities And Stockholders Equity is expected to rise to about 22.2 M this year
Last ReportedProjected for Next Year
Book Value Per Share 0.03  0.03 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 0.01  0.01 
Enterprise Value Over EBITDA(639.08)(671.04)
Price Book Value Ratio 222.20  233.31 
Enterprise Value Multiple(639.08)(671.04)
Price Fair Value 222.20  233.31 
Enterprise Value1.7 B1.8 B
The analysis of Nukkleus' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Nukkleus' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Nukkleus Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
(0.29)

Technical Drivers

As of the 24th of April, Nukkleus secures the Downside Deviation of 8.82, mean deviation of 7.51, and Risk Adjusted Performance of 0.0467. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nukkleus, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect data for nineteen technical drivers for Nukkleus, which can be compared to its peers in the industry. Please verify Nukkleus coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if Nukkleus is priced some-what accurately, providing market reflects its recent price of 0.96 per share. Given that Nukkleus is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.

Nukkleus Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Nukkleus middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Nukkleus. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Nukkleus Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Nukkleus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Nukkleus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Nukkleus insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Nukkleus Predictive Daily Indicators

Nukkleus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Nukkleus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Nukkleus Forecast Models

Nukkleus' time-series forecasting models are one of many Nukkleus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nukkleus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Nukkleus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nukkleus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nukkleus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nukkleus. By using and applying Nukkleus Stock analysis, traders can create a robust methodology for identifying Nukkleus entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(0.50)(0.47)
Operating Profit Margin(0.47)(0.44)
Net Loss(0.68)(0.64)
Gross Profit Margin(0.04)(0.03)

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Nukkleus to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Pair Correlation Now

   

Pair Correlation

Compare performance and examine fundamental relationship between any two equity instruments
All  Next Launch Module
When determining whether Nukkleus is a strong investment it is important to analyze Nukkleus' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nukkleus' future performance. For an informed investment choice regarding Nukkleus Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nukkleus. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Nukkleus Stock please use our How to buy in Nukkleus Stock guide.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Nukkleus Stock analysis

When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is Nukkleus' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.02)
Revenue Per Share
0.061
Quarterly Revenue Growth
0.012
Return On Assets
(0.16)
Return On Equity
(0.75)
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.